COLUMBUS REGIONAL HEALTHCARE SYSTEM
1. Target Overview & Investment Thesis
COLUMBUS REGIONAL HEALTHCARE SYSTEM is a 154-bed suburban community hospital in COLUMBUS, NC with $107.0M in net patient revenue and a 3.8% operating margin. The hospital serves a payer mix of 32.5% Medicare, 5.0% Medicaid, and 62.5% commercial.
Thesis: Undervalued. Our ML models identify $7.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 3.8% to 11.2% (+736bps).
| Net Revenue HCRIS | $107.0M |
| Current EBITDA COMPUTED | $4.1M |
| Operating Margin COMPUTED | 3.8% |
| Occupancy HCRIS | 34.5% |
| Revenue / Bed COMPUTED | $695K |
| Net-to-Gross HCRIS | 27.5% |
| Distress Probability ML | 52.8% |
2. Market Context & Competitive Position
NC has 129 Medicare-certified hospitals with a median operating margin of -2.0%. The target's margin of 3.8% places it above the state median. Among 53 size-comparable peers (77-308 beds), the median margin is -1.2%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (77-308), prioritizing same-state peers. 53 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| COLUMBUS REGIONAL HEALTHCARE S (Target) | NC | 154 | $107.0M | 3.8% |
| DUKE RALEIGH HOSPITAL | NC | 186 | $683.0M | 3.7% |
| CATAWBA VALLEY MEDICAL CENTER | NC | 200 | $451.9M | 5.9% |
| DUKE REGIONAL HOSPITAL | NC | 301 | $421.0M | -19.8% |
| HIGH POINT MEDICAL CENTER | NC | 288 | $406.1M | 0.3% |
| MARGARET R. PARDEE MEMORIAL HO | NC | 160 | $341.3M | -5.7% |
| JOHNSTON HEALTH | NC | 179 | $331.7M | 9.6% |
| WAKE MED CARY HOSPITAL | NC | 189 | $318.1M | -3.6% |
| ATRIUM HEALTH CLEVELAND | NC | 308 | $305.8M | 1.8% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $7.9M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $2.2M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $2.1M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $2.1M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $1.3M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $68K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $4.1M |
| + RCM Uplift | +$7.9M |
| Pro Forma EBITDA | $12.0M |
| Current Margin | 3.8% |
| Pro Forma Margin | 11.2% |
| WC Released (1x) | $4.1M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $6.3M | $105.8M | 16.76x | 75.7% |
| Base (11x exit) | 10.0x | 11.0x | $6.3M | $118.5M | 18.76x | 79.7% |
| Bull Case | 9.0x | 11.0x | $5.7M | $146.5M | 25.78x | 91.5% |
| Bull (12x exit) | 9.0x | 12.0x | $5.7M | $161.5M | 28.42x | 95.3% |
| Bear Case | 11.0x | 10.0x | $6.9M | $64.4M | 9.27x | 56.1% |
| Bear (11x exit) | 11.0x | 11.0x | $6.9M | $73.1M | 10.52x | 60.1% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Low occupancy | At 34.5%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case |
| High | Elevated distress probability | Model estimates 52.8% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 53 hospitals with 77-308 beds
- Same-state prioritization (n=54)
- Comp margins: P25=-6.6% / P50=-1.2% / P75=7.5%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.